ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway (Q84752497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Ping Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Xicai Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Tian Feng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Haifeng Zou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ying Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Zijun Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Dandan Zhao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Xiaoguang Yu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

12 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

235-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21837402%20AND%20SRC:MED&resulttype=core&format=json

Molecular determinants of Akt-induced keratinocyte transformation

10 February 2020

cites work

1 reference

12 December 2020

Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells

1 reference

12 December 2020

An essential role for ectodomain shedding in mammalian development

1 reference

12 December 2020

Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.

1 reference

12 December 2020

TACE is required for the activation of the EGFR by TGF-alpha in tumors

1 reference

12 December 2020

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

12 December 2020

Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapy

1 reference

12 December 2020

Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer

1 reference

12 December 2020

ADAMs: key components in EGFR signalling and development

1 reference

12 December 2020

Multiple intracellular MAP kinase signaling cascades

1 reference

12 December 2020

WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases

1 reference

12 December 2020

Regulation of cyclin-Cdk activity in mammalian cells

1 reference

12 December 2020

Cyclin-dependent kinase pathways as targets for cancer treatment

1 reference

12 December 2020

The MAPK signaling cascade

1 reference

12 December 2020

Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21

1 reference

12 December 2020

Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue

1 reference

12 December 2020

Cdk1/P34Cdc2 and P21waf expression in colorectal adenomas and carcinomas.

1 reference

12 December 2020

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor

1 reference

12 December 2020

TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase

1 reference

12 December 2020

Population screening for prostate cancer and emerging concepts for young men.

1 reference

12 December 2020

Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme

1 reference

12 December 2020

Proteasome subunit LMP2 is required for matrix metalloproteinase-2 and -9 expression and activities in human invasive extravillous trophoblast cell line.

1 reference

12 December 2020

Androgen-repressed phenotype in human prostate cancer

1 reference

12 December 2020

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

12 December 2020

ADAMs, cell migration and cancer

1 reference

12 December 2020

Targeting TACE-dependent EGFR ligand shedding in breast cancer

1 reference

12 December 2020

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells

1 reference

12 December 2020

UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes

1 reference

12 December 2020

TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells

1 reference

12 December 2020

Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Activity and nature of p21(WAF1) complexes during the cell cycle

1 reference

12 December 2020

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor

1 reference

12 December 2020

Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas

1 reference

12 December 2020

Androgen deprivation and other treatments for advanced prostate cancer

1 reference

12 December 2020

Changes of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA

1 reference

12 December 2020

Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor

1 reference

12 December 2020

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability

1 reference

12 December 2020

Cell cycle, CDKs and cancer: a changing paradigm

1 reference

12 December 2020

EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing

1 reference

12 December 2020

Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human

1 reference

12 December 2020

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

1 reference

12 December 2020

ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation

1 reference

12 December 2020